This inventor holds 3 USPTO granted patents. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2017
Title: Reynalda DeJesus: Innovator in Metallo-Beta-Lactamase Inhibitors
Introduction
Reynalda DeJesus is a prominent inventor based in East Brunswick, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of metallo-beta-lactamase inhibitors. With a total of three patents to her name, her work is crucial in addressing antibiotic resistance.
Latest Patents
One of her latest patents is titled "Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitors." This invention relates to compounds that serve as metallo-beta-lactamase inhibitors, detailing their synthesis and application alongside beta-lactam antibiotics to overcome resistance. Another patent, also focused on metallo-beta-lactamase inhibitors, emphasizes similar compounds and their synthesis for combating antibiotic resistance.
Career Highlights
Reynalda DeJesus is currently employed at Merck Sharp & Dohme Corporation, a leading global healthcare company. Her role involves extensive research and development in the pharmaceutical sector, where she applies her expertise to innovate solutions for pressing health challenges.
Collaborations
Throughout her career, Reynalda has collaborated with notable colleagues, including Haifeng Tang and Mihir Mandal. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking inventions.
Conclusion
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile